Randy Teel - 12 Feb 2026 Form 3 Insider Report for ARVINAS, INC. (ARVN)

Role: President and CEO, Director
Signature: /s/ Jared Freedberg, as attorney-in-fact for Randy Teel
Issuer symbol: ARVN
Transactions as of: 12 Feb 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Feb 2026, 18:09:43 UTC
Previous filing: 23 May 2024
Next filing: 18 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Teel Randy	President and CEO, Director	C/O ARVINAS, INC., 5 SCIENCE PARK, 395 WINCHESTER AVE., NEW HAVEN	/s/ Jared Freedberg, as attorney-in-fact for Randy Teel	18 Feb 2026	0002015998

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ARVN	Common Stock						12,396	12 Feb 2026	Direct	F1
holding	ARVN	Common Stock						59,600	12 Feb 2026	Direct	F2
holding	ARVN	Common Stock						46,638	12 Feb 2026	Direct	F3
holding	ARVN	Common Stock						11,072	12 Feb 2026	Direct	F4
holding	ARVN	Common Stock						18,713	12 Feb 2026	Direct	F5
holding	ARVN	Common Stock						10,466	12 Feb 2026	Direct	F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ARVN	Stock Option (right to buy)							12 Feb 2026	Common Stock	91,000	$6.61	Direct	F7
holding	ARVN	Stock Option (right to buy)							12 Feb 2026	Common Stock	71,212	$17.67	Direct	F8
holding	ARVN	Stock Option (right to buy)							12 Feb 2026	Common Stock	19,675	$34.65	Direct	F9
holding	ARVN	Stock Option (right to buy)							12 Feb 2026	Common Stock	34,161	$47.00	Direct	F10
holding	ARVN	Stock Option (right to buy)							12 Feb 2026	Common Stock	38,350	$34.37	Direct	F11
holding	ARVN	Stock Option (right to buy)							12 Feb 2026	Common Stock	52,400	$64.19	Direct	F12
holding	ARVN	Stock Option (right to buy)							12 Feb 2026	Common Stock	37,000	$78.30	Direct	F13
holding	ARVN	Stock Option (right to buy)							12 Feb 2026	Common Stock	40,000	$47.38	Direct	F14
holding	ARVN	Stock Option (right to buy)							12 Feb 2026	Common Stock	46,945	$19.36	Direct	F15
holding	ARVN	Stock Option (right to buy)							12 Feb 2026	Common Stock	104,605	$16.00	Direct	F16

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 1,509 shares of common stock of the Issuer previously purchased by the reporting person under the issuer's 2018 Employee Stock Purchase Plan.
F2	The restricted stock units (each, an "RSU") were granted by the Issuer on May 9, 2025, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs vest over two years: 1/2 of the shares underlying the award will vest on May 9, 2026, with the remainder of the shares vesting on May 9, 2027, subject to the reporting person's continued service with the Issuer on each vesting date.
F3	The RSUs were granted by the Issuer on February 13, 2025, pursuant to its Plan and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs vest over four years: 25% of the RSUs will vest on each of February 13, 2026, February 13, 2027, February 13, 2028 and February 13, 2029, subject to the reporting person's continued service with the Issuer on each vesting date.
F4	The RSUs were granted by the Issuer on May 21, 2024, in connection with the reporting person being named as Chief Business Officer of the Issuer, pursuant to its Plan and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs vest over two years: 1/2 of the shares underlying the award vested on May 21, 2025, with the remainder of the shares vesting on May 21, 2026, subject to the reporting person's continued service with the Issuer on each vesting date. The RSU amount reflects that 2,228 shares were sold to pay for taxes following the May 21, 2025 vesting.
F5	The RSUs were granted by the Issuer on February 23, 2024, pursuant to its Plan and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs vest over two years: 1/2 of the shares underlying the award vested on February 23, 2025, with the remainder of the shares vesting in on February 23, 2026, subject to the reporting person's continued service with the Issuer on each vesting date. The RSU amount reflects that 4,380 shares were sold to pay for taxes following the February 23, 2025 vesting.
F6	The RSUs were granted by the Issuer on February 22, 2023, pursuant to the Plan and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs vest over four years: 25% of the RSUs vested on each of February 22, 2024 and February 22, 2025, with the remaining RSUs vesting on each of February 22, 2026 and February 22, 2027, subject to the reporting person's continued service with the Issuer on each vesting date. The RSU amount reflects that 1,184 and 1,125 shares were sold to pay for taxes following the February 22, 2024 and February 22, 29025 vestings, respectively.
F7	The option was granted by the Issuer on May 9, 2025, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on May 9, 2026, with the remainder of the shares vesting on May 9, 2027, subject to the reporting person's continued service with the Issuer on each vesting date.
F8	The option was granted by the Issuer on February 13, 2025, pursuant to the Plan. The shares underlying the option vest over four years: 1/4 of the shares underlying the award will vest on February 13, 2026, with the remainder of the shares vesting in equal monthly installments following February 13, 2026 through February 13, 2029, subject to the reporting person's continued service with the Issuer on each vesting date.
F9	The option was granted by the Issuer on May 21, 2024, in connection with the reporting person being named as Chief Business Officer of the Issuer, pursuant to the Plan. The shares underlying the option vest over two years: 1/2 of the shares underlying the award vested on May 21, 2025, with the remainder of the shares vesting on May 21, 2026, subject to the reporting person's continued service with the Issuer on each vesting date.
F10	The option was granted by the Issuer on February 23, 2024, pursuant to the Plan. The shares underlying the option vest over two years: 1/2 of the shares underlying the award vested on February 23, 2025, with the remainder of the shares vesting on February 23, 2026, subject to the reporting person's continued service with the Issuer on each vesting date.
F11	The option was granted by the Issuer on February 22, 2023, pursuant to the Plan. The shares underlying the option vest over four years: 1/4 of the shares underlying the award vested on February 22, 2024, with the remainder of the shares vesting in equal monthly installments following February 22, 2024 through February 23, 2027, subject to the reporting person's continued service with the Issuer on each vesting date.
F12	The option was granted by the Issuer on February 23, 2022, pursuant to the Plan. The shares underlying the option vest over four years: 1/4 of the shares underlying the award vested on February 23, 2023, with the remainder of the shares vesting in equal monthly installments following February 23, 2023 through February 23, 2026, subject to the reporting person's continued service with the Issuer on each vesting date.
F13	The option was granted by the Issuer on February 26, 2021, pursuant to the Plan. The shares underlying the option vested over four years: 1/4 of the shares underlying the award vested on February 26, 2022, and the remainder of the shares vested in equal monthly installments following February 23, 2022 through February 23, 2025.
F14	The option was granted by the Issuer on February 27, 2020, pursuant to the Plan. The shares underlying the option vested over four years: 1/4 of the shares underlying the award vested on February 27, 2021, and the remainder of the shares vested in equal monthly installments following February 27, 2021 through February 27, 2024.
F15	The option was granted by the Issuer on March 1, 2019, pursuant to the Plan. The shares underlying the option vested over four years: 1/4 of the shares underlying the award vested on March 1, 2020, and the remainder of the shares vested in equal monthly installments following March 1, 2020 through March 1, 2023.
F16	The option was granted by the Issuer on September 26, 2018, pursuant to the Plan. The shares underlying the option vested over four years: 1/4 of the shares underlying the award vested on May 14, 2019, and the remainder of the shares vested in equal monthly installments following May 14, 2019 through May 14, 2022.